The production of mycelium-based product and ingredients isn’t just about innovation and discovery anymore, it’s also about industrial scale-up to drive price parity with traditional protein sources.

The news that mycoprotein companies such as Adamo Foods https://lnkd.in/dze-uxV5 continue to attract significant funding and support to develop and scale their technology is a win for the entire sector. It’s a strong market endorsement of the potential of mycelium-based fermentation to play a key role in addressing the significant challenge we face in meeting the protein needs of future generations is increasingly. Likewise, that the appetite for “Engineered by Nature” nutritional solutions is accelerating.

The “Fungi Moment” and excitement of novel new discoveries may remain. However, as importantly it’s about the unit economics of proving that mycoprotein protein products can reach price parity with traditional protein sources such as beef by moving from lab-scale success to industrial scale production platforms.

At MycoSure, we are closely watching these global developments as our own business transitions from R&D to product formulation and commercialisation. MycoSure is proud to be part of a global cohort of companies turning mycelium into high-quality, sustainable protein products.